Besides being a Bio stock, what is it that makes this a good company worth investing in?
Are there interesting new drugs in the pipeline? Clinical trials? Marijuana (CBD) tie-in?
I looked at part of the most recent 10-Q.......they seem to be operating at a loss, which to me is no big surprise.
Do you have any info about how they are raising capital, besides selling stock? Any info regarding the ties to Frontier?
Are there interesting new drugs in the pipeline? Clinical trials? Marijuana (CBD) tie-in?
I looked at part of the most recent 10-Q.......they seem to be operating at a loss, which to me is no big surprise.
Do you have any info about how they are raising capital, besides selling stock? Any info regarding the ties to Frontier?
Recent MBIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:01:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:01:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:05:32 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/05/2026 10:00:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 09:15:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:05:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/03/2025 09:05:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:06:17 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/05/2025 08:01:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:05:51 PM
- Mustang Bio Shares Surge After FDA Grants Orphan Drug Status • IH Market News • 07/07/2025 01:29:52 PM
- Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma • GlobeNewswire Inc. • 07/07/2025 12:30:55 PM
